Skip to main content

Trofinetide use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Jul 12, 2023.

Drugs containing Trofinetide: Daybue

Trofinetide Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of trofinetide during breastfeeding. If trofinetide is required by the mother, it is not a reason to discontinue breastfeeding. Until more data are available, trofinetide should be used with careful infant monitoring for diarrhea and proper weight gain.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Trofinetide

CAS Registry Number

853400-76-7

Drug Class

Breast Feeding

Lactation

Milk, Human

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.